WELCOME TO THE MANUFACTURING REPORT
Newsletter | Member Login | Signup
Home > Companies > Align Technology
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Conference
3D Printing
Align Technology | September 20, 2023
Align announced its agreement to acquire Cubicure GmbH. Cubicure's technology employs a mechanism that enables the processing of extremely viscous resins, facilitating unprecedented adiitive manufacturing. The transaction's purchase price, anticipated to close in the fourth quarter of 2023 or early in 2024 will be nearly €79 million. Read More
Manufacturing Technology
Align Technology, Inc. | September 16, 2022
Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM services for orthodontic and restorative dentistry, today announced the official opening of the first Europe, Middle East & Africa (EMEA) regional manufacturing facility in Wroclaw, Poland. The new plant is Align’s third regional manufacturing fa...
Keppel Offshore & Marine, Lloyd's Register | January 14, 2020
Keppel Offshore & Marine has received Lloyd’s Register LR Certification to additively manufacture offshore grade steel with a 3D printing technology from Singapore Institute of Manufacturing Technology SIMTech. The certification was granted after assessing Keppel O&M’s production processes, from design to post-processing and testing. Partnering with Nanyang Technological University, Singapore NTU Singapore and SIMTech’s Agency for Science, Technology and Research A*STAR...
Outsourcing-Pharma.com | January 13, 2020
BMS and Catalent disclosed the deal for the site in June, at which time they hoped to work through the regulatory approvals and union consultations needed to close the transaction by the end of the year. One week into 2020, Bristol-Myers revealed it had closed the deal. The deal covers a 19,300-square-meter manufacturing facility in Anagni, a town in central Italy, that lists cardiovascular, neuroleptics, anticancer, metabolic and anti-inflammatory medicines among the drugs it makes and packages...
Industrial 4.0
Article
Video
Whitepaper
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE